Shopping Cart 0
Cart Subtotal
AED 0

Aprecia Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Aprecia Pharmaceuticals LLC (Aprecia Pharmaceuticals) is a drug delivery technology platform company that develops pharma-ready patient-centric products. The company offers Zipdose technology, a delivery platform that serves as the foundation of orodispersible formulations of prescribed high-dose medications. It also provides 3D printing technology platform that uses an aqueous fluid to stitch together multiple layers of powder using patent-protected process. Aprecia offers SPRITAM levetiracetam tablet for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy. The company has operations with office in New Jersey, the US. Aprecia is headquartered in Blue Ash, Ohio, the US.

Aprecia Pharmaceuticals LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aprecia Pharmaceuticals LLC, Medical Devices Deals, 2012 to YTD 2018 9

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Aprecia Pharma Raises Funds in Financing Round 11

Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12

Aprecia Pharma Raises USD 15 Million In Venture Financing 13

Aprecia Pharma Raises USD 4 Million In Venture Financing 14

Partnerships 15

Aprecia Pharma and Cycle Pharma Enter into Agreement 15

Acquisition 16

Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16

Aprecia Pharmaceuticals LLC-Key Competitors 17

Aprecia Pharmaceuticals LLC-Key Employees 18

Aprecia Pharmaceuticals LLC-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Corporate Communications 20

Nov 01, 2017: Aprecia Pharmaceuticals Names University of Kentucky Provost as the Company's Next CEO 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aprecia Pharmaceuticals LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aprecia Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Aprecia Pharmaceuticals LLC, Medical Devices Deals, 2012 to YTD 2018 9

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Aprecia Pharma Raises Funds in Financing Round 11

Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12

Aprecia Pharma Raises USD 15 Million In Venture Financing 13

Aprecia Pharma Raises USD 4 Million In Venture Financing 14

Aprecia Pharma and Cycle Pharma Enter into Agreement 15

Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16

Aprecia Pharmaceuticals LLC, Key Competitors 17

Aprecia Pharmaceuticals LLC, Key Employees 18

Aprecia Pharmaceuticals LLC, Other Locations 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Aprecia Pharmaceuticals LLC (Aprecia Pharmaceuticals) is a drug delivery technology platform company that develops pharma-ready patient-centric products. The company offers Zipdose technology, a delivery platform that serves as the foundation of orodispersible formulations of prescribed high-dose medications. It also provides 3D printing technology platform that uses an aqueous fluid to stitch together multiple layers of powder using patent-protected process. Aprecia offers SPRITAM levetiracetam tablet for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy. The company has operations with office in New Jersey, the US. Aprecia is headquartered in Blue Ash, Ohio, the US.

Aprecia Pharmaceuticals LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aprecia Pharmaceuticals LLC, Medical Devices Deals, 2012 to YTD 2018 9

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Aprecia Pharma Raises Funds in Financing Round 11

Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12

Aprecia Pharma Raises USD 15 Million In Venture Financing 13

Aprecia Pharma Raises USD 4 Million In Venture Financing 14

Partnerships 15

Aprecia Pharma and Cycle Pharma Enter into Agreement 15

Acquisition 16

Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16

Aprecia Pharmaceuticals LLC-Key Competitors 17

Aprecia Pharmaceuticals LLC-Key Employees 18

Aprecia Pharmaceuticals LLC-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Corporate Communications 20

Nov 01, 2017: Aprecia Pharmaceuticals Names University of Kentucky Provost as the Company's Next CEO 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aprecia Pharmaceuticals LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aprecia Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Aprecia Pharmaceuticals LLC, Medical Devices Deals, 2012 to YTD 2018 9

Aprecia Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Aprecia Pharma Raises Funds in Financing Round 11

Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12

Aprecia Pharma Raises USD 15 Million In Venture Financing 13

Aprecia Pharma Raises USD 4 Million In Venture Financing 14

Aprecia Pharma and Cycle Pharma Enter into Agreement 15

Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16

Aprecia Pharmaceuticals LLC, Key Competitors 17

Aprecia Pharmaceuticals LLC, Key Employees 18

Aprecia Pharmaceuticals LLC, Other Locations 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS